Woodline Partners LP Iovance Biotherapeutics, Inc. Transaction History

Woodline Partners LP

$17.6 Billion
Q2 2025

A detailed history of Woodline Partners LP transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 567,680 shares of IOVA stock, worth $1.12 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

567,680

Previous 566,915 0.13%

Holding current value

$1.12 Million

Previous $1.89 Million 48.28%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$1.66 - $3.61 $1,269 - $2,761	765 Added 0.13%	567,680 $976,000
Q1 2025 May 15, 2025	BUY	$3.33 - $7.79 $11,115 - $26,003	3,338 Added 0.59%	566,915 $1.89 Million
Q4 2024 Feb 14, 2025	BUY	$7.17 - $12.28 $8,188 - $14,023	1,142 Added 0.2%	563,577 $4.17 Million
Q3 2024 Nov 14, 2024	BUY	$7.28 - $11.9 $4.09 Million - $6.69 Million	562,435 New	562,435 $5.28 Million
Q1 2024 May 15, 2024	SELL	$7.59 - $17.47 $924,818 - $2.13 Million	-121,847 Reduced 7.59%	1,482,859 $22 Million
Q4 2023 Feb 14, 2024	BUY	$3.3 - $8.89 $3.16 Million - $8.52 Million	958,411 Added 148.29%	1,604,706 $13 Million
Q3 2023 Nov 14, 2023	BUY	$4.44 - $8.79 $2.87 Million - $5.68 Million	646,295 New	646,295 $2.94 Million
Q3 2022 Nov 14, 2022	SELL	$9.53 - $13.11 $2.27 Million - $3.13 Million	-238,636 Reduced 47.75%	261,134 $2.5 Million
Q2 2022 Aug 15, 2022	BUY	$6.38 - $18.33 $2 Million - $5.74 Million	312,906 Added 167.45%	499,770 $5.52 Million
Q1 2022 May 16, 2022	SELL	$12.38 - $19.1 $5.35 Million - $8.25 Million	-431,839 Reduced 69.8%	186,864 $3.11 Million
Q4 2021 Feb 14, 2022	BUY	$16.55 - $27.63 $7.17 Million - $12 Million	433,151 Added 233.44%	618,703 $11.8 Million
Q3 2021 Nov 15, 2021	BUY	$20.35 - $26.63 $3.78 Million - $4.94 Million	185,552 New	185,552 $4.58 Million
Q2 2021 Aug 16, 2021	SELL	$16.33 - $33.07 $4.53 Million - $9.18 Million	-277,523 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$28.67 - $52.59 $7.34 Million - $13.5 Million	255,949 Added 1186.38%	277,523 $8.79 Million
Q4 2020 Feb 16, 2021	SELL	$28.04 - $50.26 $4.97 Million - $8.9 Million	-177,110 Reduced 89.14%	21,574 $1 Million
Q3 2020 Nov 16, 2020	BUY	$27.75 - $36.3 $5.51 Million - $7.21 Million	198,684 New	198,684 $6.54 Million
Q2 2020 Aug 14, 2020	SELL	$27.21 - $41.0 $7.63 Million - $11.5 Million	-280,498 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$19.54 - $38.85 $2.69 Million - $5.36 Million	137,857 Added 96.65%	280,498 $8.4 Million
Q4 2019 Feb 14, 2020	BUY	$17.95 - $29.41 $2.56 Million - $4.2 Million	142,641 New	142,641 $3.95 Million

Others Institutions Holding IOVA

# of Institutions

297

Shares Held

234M

Call Options Held

1.14M

Put Options Held

1.15M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $311M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Account

Woodline Partners LP Iovance Biotherapeutics, Inc. Transaction History